In AD specifically, the CB1 mRNA levels were shown to be increased in the 3xTgAD mouse model in the prefrontal cortex (PFC), dorsal hippocampus (DH), and basolateral amygdala complex (BLA) at 6 and 12 months of age [46]. Here, CNR1 is linked to Alzheimer disease.